Holen Sie sich die Stockscreener-App
38.50
4.09%
-1.64
Handel nachbörslich:
38.43
-0.07
-0.18%
Schlusskurs vom Vortag:
$40.14
Offen:
$40.36
24-Stunden-Volumen:
1.62M
Relative Volume:
1.24
Marktkapitalisierung:
$3.10B
Einnahmen:
$541.74M
Nettoeinkommen (Verlust:
$88.01M
KGV:
35.44
EPS:
1.0862
Netto-Cashflow:
$155.34M
1W Leistung:
-12.22%
1M Leistung:
-6.67%
6M Leistung:
+16.95%
1J Leistung:
+19.27%
1-Tages-Spanne:
$38.24
$41.45
1-Wochen-Bereich:
$38.24
$43.78
52-Wochen-Spanne:
$29.45
$60.91
Veracyte Inc Stock (VCYT) Company Profile
Firmenname
Veracyte Inc
Sektor
Branche
Telefon
(650) 243-6300
Adresse
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Compare VCYT vs TMO, DHR, NTRA, IQV, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
38.50 | 3.29B | 541.74M | 88.01M | 155.34M | 1.0862 |
TMO
Thermo Fisher Scientific Inc
|
648.43 | 225.48B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
208.36 | 140.70B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
345.34 | 47.41B | 2.50B | -226.32M | 71.51M | -1.6412 |
IQV
Iqvia Holdings Inc
|
268.82 | 43.09B | 16.63B | 1.39B | 2.12B | 8.0674 |
A
Agilent Technologies Inc
|
153.69 | 41.42B | 7.23B | 1.41B | 1.09B | 4.979 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-13 | Eingeleitet | Jefferies | Buy |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Underweight |
| 2025-10-20 | Eingeleitet | Canaccord Genuity | Hold |
| 2025-03-20 | Eingeleitet | Craig Hallum | Buy |
| 2024-12-05 | Herabstufung | Goldman | Buy → Neutral |
| 2024-11-15 | Eingeleitet | Wolfe Research | Outperform |
| 2024-10-16 | Eingeleitet | UBS | Buy |
| 2024-10-10 | Eingeleitet | Guggenheim | Buy |
| 2024-02-23 | Bestätigt | Needham | Buy |
| 2023-01-18 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-01-07 | Eingeleitet | Stephens | Overweight |
| 2021-11-18 | Fortgesetzt | Goldman | Buy |
| 2021-06-15 | Eingeleitet | Raymond James | Outperform |
| 2021-02-18 | Fortgesetzt | Needham | Buy |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Underweight |
| 2019-07-31 | Eingeleitet | Lake Street | Buy |
| 2019-07-02 | Eingeleitet | Needham | Buy |
| 2018-11-29 | Herabstufung | Janney | Buy → Neutral |
| 2018-10-31 | Hochstufung | Janney | Neutral → Buy |
| 2017-11-07 | Herabstufung | Janney | Buy → Neutral |
| 2017-11-07 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-08-31 | Fortgesetzt | BTIG Research | Buy |
| 2016-11-14 | Fortgesetzt | Leerink Partners | Outperform |
| 2015-12-18 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2015-06-11 | Bestätigt | Leerink Partners | Outperform |
| 2013-11-26 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Veracyte Inc Aktie (VCYT) Neueste Nachrichten
COO Q3 Earnings Top Estimates, Revenues Miss on Destocking, Stock Down - Zacks Investment Research
Veracyte (VCYT) Gets a Buy from UBS - theglobeandmail.com
Zacks Industry Outlook Highlights Veracyte, Globus Medical and UFP Technologies - Yahoo Finance
Veracyte Inc (VCYT) Shares Surge 3.3% -- What GF Score of 81 Tel - GuruFocus
VCYT Maintains Buy Rating by UBS -- Price Target Raised to $65 - GuruFocus
UBS Adjusts Price Target on Veracyte to $65 From $52, Keeps Buy Rating - marketscreener.com
Veracyte CFO Rebecca Chambers Forfeits 3,603 Shares at $44.88 and Sells Additional Shares in Early September - Kalkine Media
VERACYTE Executive Leite John Forfeits 3,961 Shares at $44.88 Each (NASDAQ: VCYT) - Kalkine Media
Earnings Preview: Veracyte (VCYT) Q2 Earnings Expected to Decline - Eastern Progress
Chief Scientific & Medical Officer Of Veracyte Sold 33% Of Their Shares - simplywall.st
Veracyte CFO Rebecca Chambers sells $157,394 in VCYT shares By Investing.com - Investing.com Australia
Veracyte EVP, general counsel Annie McGuire sells over $140,000 in stock By Investing.com - Investing.com South Africa
Veracyte chief scientific & med officer sells over $564k stock - Investing.com Nigeria
Veracyte EVP, general counsel Annie McGuire sells over $140,000 in stock - Investing.com Nigeria
Veracyte chief scientific & med officer sells over $564k stock By Investing.com - Investing.com South Africa
Veracyte CFO Rebecca Chambers sells $157,394 in VCYT shares - Investing.com India
Veracyte (VCYT) CFO stock sale alongside tax share withholding - Stock Titan
Veracyte Inc (VCYT) Shares Fall 4.8% -- GF Value Says Still Over - GuruFocus
VCYT News | VERACYTE INC (NASDAQ:VCYT) - ChartMill
Veracyte (NASDAQ: VCYT) CAO has RSU shares withheld for taxes - Stock Titan
Veracyte (VCYT) insider sells 13,110 shares under pre-set plan - Stock Titan
Veracyte (VCYT) CCO logs tax withholding, not sale - Stock Titan
Veracyte (VCYT) CEO holds 432,073 shares after tax withholding - Stock Titan
Veracyte (NASDAQ: VCYT) officer lines up 3,254-share stock sale - Stock Titan
Veracyte (NASDAQ: VCYT) officer to sell 3,652 shares - Stock Titan
Officer plans stock sale in Veracyte (NASDAQ: VCYT) - Stock Titan
Veracyte (VCYT) Director Muna Bhanji Sells 1,864 Shares - GuruFocus
Veracyte (VCYT) director sells 1,864 shares in pre-planned trade - Stock Titan
The Technical Signals Behind (VCYT) That Institutions Follow - Stock Traders Daily
Muna Bhanji plans sale of 3,728 Veracyte (NASDAQ: VCYT) shares - Stock Titan
Veracyte Inc. (VCYT) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
Cathie Wood’s ARK sells Tempus AI stock, buys Veracyte By Investing.com - Investing.com Nigeria
Cathie Wood’s ARK sells Tempus AI stock, buys Veracyte - investing.com
Is it Worth Adding Veracyte Stock to Your Portfolio Now? - Yahoo Finance
VCYT Drops 25.3% in the Past Month. Is the Sell-Off an Opportunity? - TradingView
Virtus Advisers LLC Purchases New Shares in Veracyte, Inc. $VCYT - MarketBeat
Great Lakes Advisors LLC Invests $3.85 Million in Veracyte, Inc. $VCYT - MarketBeat
Veracyte (VCYT): Moves 0.50% Down to $41.98 on the Day; Trading Range: the Price Remains Bounded by the Supplied Support and ResistanceDividend Arbitrage - vinanet.vn
Lisanti Capital Growth LLC Purchases Shares of 63,400 Veracyte, Inc. $VCYT - MarketBeat
Top 3 Health Care Stocks That Could Blast Off This Month - Benzinga
Summit Creek Advisors LLC Takes Position in Veracyte, Inc. $VCYT - MarketBeat
Veracyte (VCYT) Results at a Glance: EPS Clears the Reported Estimate in Latest Trading; Stock Move: Shares Move Lower 2.50%Investor Earnings Call - vinanet.vn
Rice Hall James & Associates LLC Invests $5.61 Million in Veracyte, Inc. $VCYT - MarketBeat
Veracyte Inc (VCYT) News, Articles, Events & Latest Updates - Stocktwits
Down 30.2% in 4 Weeks, Here's Why Veracyte (VCYT) Looks Ripe for a Turnaround - Yahoo Finance
Is Veracyte (VCYT) Undervalued As Raised 2026 Outlook And Q2 Earnings Lift Interest? - Sahm
Veracyte Inc (VCYT) Shares Fall 3.2% -- GF Value Says Still Over - GuruFocus
Veracyte Debuts Prosigna Breast Test in the U.S. - Medical Product Outsourcing
Zacks Research Upgrades Veracyte (NASDAQ:VCYT) to Strong-Buy - MarketBeat
Bank of America Corp DE Grows Stock Position in Veracyte, Inc. $VCYT - MarketBeat
Veracyte, Inc. (VCYT) Stock Forecasts - Yahoo Finance
Finanzdaten der Veracyte Inc-Aktie (VCYT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Veracyte Inc-Aktie (VCYT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Febbo Phillip G. | Chief Scientific & Med Officer |
Sep 04 '26 |
Sale |
43.05 |
13,110 |
564,410 |
133,048 |
| Chambers Rebecca | Chief Financial Officer |
Sep 04 '26 |
Sale |
43.10 |
3,652 |
157,394 |
166,025 |
| McGuire Annie | EVP, General Counsel |
Sep 04 '26 |
Sale |
43.09 |
3,254 |
140,212 |
131,160 |
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):